![](/images/general/no_picture/200_user.png)
Chandrika Prasad
Examiner (ID: 17499, Phone: (571)272-2099 , Office: P/2831 )
Most Active Art Unit | 2839 |
Art Unit(s) | 2833, 2839, 2831 |
Total Applications | 2897 |
Issued Applications | 2445 |
Pending Applications | 55 |
Abandoned Applications | 397 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6683859
[patent_doc_number] => 20030119723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/287195
[patent_app_country] => US
[patent_app_date] => 2002-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18643
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119723.pdf
[firstpage_image] =>[orig_patent_app_number] => 10287195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/287195 | Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides | Nov 3, 2002 | Abandoned |
Array
(
[id] => 6846837
[patent_doc_number] => 20030166004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Endothelial-cell binding peptides for diagnosis and therapy'
[patent_app_type] => new
[patent_app_number] => 10/286457
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 28214
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10286457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/286457 | Endothelial-cell binding peptides for diagnosis and therapy | Oct 31, 2002 | Abandoned |
Array
(
[id] => 6669402
[patent_doc_number] => 20030114386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Hexa-, hepta-, and octapeptides having antiangiogenic activity'
[patent_app_type] => new
[patent_app_number] => 10/283553
[patent_app_country] => US
[patent_app_date] => 2002-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15822
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114386.pdf
[firstpage_image] =>[orig_patent_app_number] => 10283553
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/283553 | Hexa-, hepta-, and octapeptides having antiangiogenic activity | Oct 29, 2002 | Issued |
Array
(
[id] => 6843606
[patent_doc_number] => 20030148953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Inactivation resistant factor VIII'
[patent_app_type] => new
[patent_app_number] => 10/283648
[patent_app_country] => US
[patent_app_date] => 2002-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 17913
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148953.pdf
[firstpage_image] =>[orig_patent_app_number] => 10283648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/283648 | Inactivation resistant factor VIII | Oct 28, 2002 | Abandoned |
Array
(
[id] => 6861619
[patent_doc_number] => 20030092627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Pharmaceutical composition comprising a factor VIIa and a factor XIII'
[patent_app_type] => new
[patent_app_number] => 10/271278
[patent_app_country] => US
[patent_app_date] => 2002-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11858
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092627.pdf
[firstpage_image] =>[orig_patent_app_number] => 10271278
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/271278 | Pharmaceutical composition comprising a factor VIIa and a factor XIII | Oct 14, 2002 | Abandoned |
Array
(
[id] => 7206451
[patent_doc_number] => 20040087498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Modified factor VII'
[patent_app_type] => new
[patent_app_number] => 10/263205
[patent_app_country] => US
[patent_app_date] => 2002-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17479
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10263205
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263205 | Modified factor VII | Sep 30, 2002 | Abandoned |
Array
(
[id] => 6801201
[patent_doc_number] => 20030096366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Method for production of recombinant proteins in eukaryote cells'
[patent_app_type] => new
[patent_app_number] => 10/254394
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9834
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096366.pdf
[firstpage_image] =>[orig_patent_app_number] => 10254394
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/254394 | Method for production of recombinant proteins in eukaryote cells | Sep 24, 2002 | Abandoned |
Array
(
[id] => 6788333
[patent_doc_number] => 20030139572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Novel compounds'
[patent_app_type] => new
[patent_app_number] => 10/239663
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14668
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20030139572.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239663 | Novel compounds | Sep 23, 2002 | Abandoned |
Array
(
[id] => 6656655
[patent_doc_number] => 20030077753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Diglycosylated erythropoietin'
[patent_app_type] => new
[patent_app_number] => 10/241356
[patent_app_country] => US
[patent_app_date] => 2002-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5573
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077753.pdf
[firstpage_image] =>[orig_patent_app_number] => 10241356
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/241356 | Diglycosylated erythropoietin | Sep 10, 2002 | Issued |
Array
(
[id] => 6861131
[patent_doc_number] => 20030092139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Process for the fermentative preparation of L-amino acids using coryneform bacteria'
[patent_app_type] => new
[patent_app_number] => 10/212219
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6084
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092139.pdf
[firstpage_image] =>[orig_patent_app_number] => 10212219
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/212219 | Process for the fermentative preparation of L-amino acids using coryneform bacteria | Aug 5, 2002 | Abandoned |
Array
(
[id] => 6706319
[patent_doc_number] => 20030153053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Methods for altering polyketide synthase genes'
[patent_app_type] => new
[patent_app_number] => 10/214424
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4173
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153053.pdf
[firstpage_image] =>[orig_patent_app_number] => 10214424
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/214424 | Methods for altering polyketide synthase genes | Aug 5, 2002 | Abandoned |
Array
(
[id] => 6683863
[patent_doc_number] => 20030119727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'FVIIa antagonists'
[patent_app_type] => new
[patent_app_number] => 10/202915
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 26822
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119727.pdf
[firstpage_image] =>[orig_patent_app_number] => 10202915
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202915 | FVIIa antagonists | Jul 24, 2002 | Issued |
Array
(
[id] => 761356
[patent_doc_number] => 07012132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-14
[patent_title] => 'Modified factor VIII'
[patent_app_type] => utility
[patent_app_number] => 10/187319
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 31128
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/012/07012132.pdf
[firstpage_image] =>[orig_patent_app_number] => 10187319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/187319 | Modified factor VIII | Jun 27, 2002 | Issued |
Array
(
[id] => 7199367
[patent_doc_number] => 20040086501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Protein having activity as an angiogenesis modulator'
[patent_app_type] => new
[patent_app_number] => 10/019065
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8813
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086501.pdf
[firstpage_image] =>[orig_patent_app_number] => 10019065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/019065 | Protein having activity as an angiogenesis modulator | May 30, 2002 | Abandoned |
10/031947 | Multi-dose erythropoietin formulations | May 14, 2002 | Abandoned |
Array
(
[id] => 758032
[patent_doc_number] => 07015193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-21
[patent_title] => 'Compositions and methods to control bleeding'
[patent_app_type] => utility
[patent_app_number] => 10/125950
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 26
[patent_no_of_words] => 13983
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10125950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/125950 | Compositions and methods to control bleeding | Apr 18, 2002 | Issued |
Array
(
[id] => 6656653
[patent_doc_number] => 20030077751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Zvwf1: a member of the von Willebrand factor type a domain superfamily'
[patent_app_type] => new
[patent_app_number] => 10/127101
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30001
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077751.pdf
[firstpage_image] =>[orig_patent_app_number] => 10127101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/127101 | Zvwf1: a member of the von Willebrand factor type a domain superfamily | Apr 18, 2002 | Abandoned |
Array
(
[id] => 6701484
[patent_doc_number] => 20030224364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci'
[patent_app_type] => new
[patent_app_number] => 10/107431
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 46176
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224364.pdf
[firstpage_image] =>[orig_patent_app_number] => 10107431
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/107431 | Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6377606
[patent_doc_number] => 20020119487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Human stem cell antigen 2'
[patent_app_type] => new
[patent_app_number] => 10/101747
[patent_app_country] => US
[patent_app_date] => 2002-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12612
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119487.pdf
[firstpage_image] =>[orig_patent_app_number] => 10101747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/101747 | Human stem cell antigen 2 | Mar 20, 2002 | Abandoned |
Array
(
[id] => 6158784
[patent_doc_number] => 20020147148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Insecticidal protein toxins from xenorhabdus'
[patent_app_type] => new
[patent_app_number] => 10/078968
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16043
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147148.pdf
[firstpage_image] =>[orig_patent_app_number] => 10078968
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/078968 | Insecticidal protein toxins from xenorhabdus | Feb 18, 2002 | Abandoned |